Effect of statins on functional outcome and mortality following aneurysmal subarachnoid hemorrhage – Results of a meta-analysis, metaregression and trial sequential analysis

• Published in: Clinical neurology and neurosurgery 2021-08, Vol.207, p.106787-106787, Article 106787
• Main Authors: Bohara, Sandeep, Gaonkar, Vishwa Bharathi, Garg, Kanwaljeet, Rajpal, Preet Mohinder Singh, Singh, Pankaj Kumar, Singh, Manmohan, Suri, Ashish, Chandra, P.S., Kale, S.S.
• Format: Article
• Language: English
• Subjects: Aneurysm; Aneurysms; Bias; Brain Ischemia - etiology; Brain Ischemia - prevention & control; Clinical trials; Collaboration; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Ischemia; Meta-analyses; Meta-analysis; Morbidity; Mortality; Neurological diseases; Recovery of Function - drug effects; Statins; Statistical analysis; Stroke; Subarachnoid hemorrhage; Subarachnoid Hemorrhage - complications; Subarachnoid Hemorrhage - mortality; Systematic review; Trial Sequential analysis; Vasoconstriction; Vasospasm; Vasospasm, Intracranial - etiology; Vasospasm, Intracranial - prevention & control
• ISSN: 0303-8467; 1872-6968
• DOI: 10.1016/j.clineuro.2021.106787

Cerebral vasospasm (CVS) and delayed ischemic neurological deficits (DIND) are a common cause of morbidity following aneurysmal subarachnoid hemorrhage (SAH). Statins have been shown to decrease CVS. The objective of this article was to ascertain the effect of statins on functional outcome and mortality following aneurysmal SAH by performing meta-analysis. A comprehensive search of different databases was performed to retrieve randomized controlled trials. Meta-analysis with subgroup analysis and metaregression was done. Trial sequential analysis (TSA) was performed to determine if the cumulative sample size was appropriately powered for the obtained pooled effect values and to avoid random error. Twelve articles were selected for meta-analysis. Pooled OR for the change in favorable outcome, mortality, CVS, DIND and elevated transaminases was 1.07 (p = 0.55), 0.78 (p = 0.17), 0.58 (p = 0.0004), 0.54 (p = 0.0293) and 0.68 (p = 0.1774) respectively. Further, subgroup analysis and metaregression showed that the use of different statin or dose did not result in significant variation in results in the parameters studied. TSA showed that more trials and patients are required to reach to a definitive conclusion regarding any effect on statins on functional outcome and mortality as the current studies neither reached the level of confidence nor crossed the futility boundary. Use of statins in patients with aneurysmal SAH resulted in marginal but non-significant favorable impact on functional outcome and mortality. TSA showed that more studies are required to get conclusive evidence in this regard. •CVS and DIND are a common cause of morbidity following aneurysmal SAH.•Statins have been shown to decrease CVS.•Use of statins results in non-significant favourable impact on outcome and mortality.•TSA showed that more studies are required to get conclusive evidence in this regard.